Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1. |
Name of the issuer PHYTOPHARM PLC |
2. |
State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006). (III) (iii) BOTH (i) AND (ii) |
|
|
|
|
3. |
Name of person discharging managerial responsibilities/director MR TIMOTHY SHARPINGTON, CHIEF EXECUTIVE
|
4. |
State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person AS 3 ABOVE |
|
|
|
|
5. |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1 AS 3 ABOVE |
6. |
Description of shares (including class), debentures or derivatives or financial instruments relating to shares OPTIONS OVER ORDINARY SHARES OF 1 PENCE EACH |
|
|
|
|
7. |
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
|
8. |
State the nature of the transaction
|
|
|
|
|
9. |
Number of shares, debentures or financial instruments relating to shares acquired
|
10. |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
|
|
|
|
|
11. |
Number of shares, debentures or financial instruments relating to shares disposed |
12. |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
|
|
|
|
|
13. |
Price per share or value of transaction
|
14. |
Date and place of transaction
|
|
|
|
|
15. |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) |
16. |
Date issuer informed of transaction
|
|
|
|
|
If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
17. |
Date of grant 24 NOVEMBER 2011
|
18. |
Period during which or date on which exercisable THESE OPTIONS SHALL BE EXERCISEABLE FROM THE THIRD ANNIVERSARY OF GRANT FOR A PERIOD OF SEVEN YEARS
|
|
|
|
|
19. |
Total amount paid (if any) for grant of the option NIL |
20. |
Description of shares or debentures involved (class and number) 886,976 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
|
|
|
|
|
21. |
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 6.525 PENCE PER SHARE
|
22. |
Total number of shares or debentures over which options held following notification 5,104,541 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES |
|
|
|
|
23. |
Any additional information
|
24. |
Name of contact and telephone number for queries ZOE MCGOWAN |
|
|
|
|
Name of authorised official of issuer responsible for making notification ZOE MCGOWAN, COMPANY SECRETARY Date of notification 28 NOVEMBER 2011
|
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) |
An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. |
(2) |
An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
(3) |
An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. |
(4) |
An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. |